Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.09)
# 512
Out of 5,149 analysts
95
Total ratings
33.98%
Success rate
22.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Maintains: Buy | $11 → $16 | $9.49 | +68.60% | 3 | Feb 27, 2026 | |
| DWTX Dogwood Therapeutics | Reiterates: Buy | $12 | $2.93 | +309.56% | 4 | Feb 20, 2026 | |
| KZIA Kazia Therapeutics | Reiterates: Buy | $18 | $10.01 | +79.82% | 7 | Jan 28, 2026 | |
| PSTV Plus Therapeutics | Maintains: Buy | $2 → $1 | $0.29 | +241.06% | 14 | Jan 23, 2026 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $11 → $27 | $17.53 | +54.02% | 4 | Jan 20, 2026 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $24 | $13.02 | +84.33% | 14 | Jan 12, 2026 | |
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.80 | -6.25% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $6.83 | +171.06% | 3 | Nov 6, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.23 | +595.65% | 2 | Sep 9, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.75 | +568.00% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $5.68 | +146.48% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $51.88 | -22.90% | 10 | Apr 1, 2025 |
Novavax
Feb 27, 2026
Maintains: Buy
Price Target: $11 → $16
Current: $9.49
Upside: +68.60%
Dogwood Therapeutics
Feb 20, 2026
Reiterates: Buy
Price Target: $12
Current: $2.93
Upside: +309.56%
Kazia Therapeutics
Jan 28, 2026
Reiterates: Buy
Price Target: $18
Current: $10.01
Upside: +79.82%
Plus Therapeutics
Jan 23, 2026
Maintains: Buy
Price Target: $2 → $1
Current: $0.29
Upside: +241.06%
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11 → $27
Current: $17.53
Upside: +54.02%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $13.02
Upside: +84.33%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.80
Upside: -6.25%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $6.83
Upside: +171.06%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.23
Upside: +595.65%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.75
Upside: +568.00%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $5.68
Upside: +146.48%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $51.88
Upside: -22.90%